RedHill Biopharma Ltd., known for its focus on gastrointestinal and infectious diseases, has recently achieved compliance with Nasdaq's minimum bid price requirement. This milestone ensures that the specialty biopharmaceutical company will continue to be listed on the Nasdaq Capital Market, a
In a significant move that is set to reshape the biopharmaceutical landscape, Tanvex BioPharma is acquiring Bora Biologics, a subsidiary of Bora Pharmaceuticals. This strategic merger aims to amalgamate the strengths of two industry leaders, creating a formidable force in the global Contract
Enhancing Manufacturing Capabilities Novartis is making significant strides in its efforts to expand manufacturing capabilities to meet the growing demand for radiopharmaceutical therapies aimed at treating cancer. To achieve this, the company is not only expanding an existing facility in
BioMarin Pharmaceutical, a renowned biotech firm known for its pioneering treatments for rare diseases, has recently embarked on a strategic overhaul aimed at revitalizing its growth trajectory. Faced with a period of stagnation marked by significant layoffs and halted projects, the company’s new
In an industry perpetually teetering on the edge of innovation and regulation, recent events in the biopharmaceutical sector underscore the volatile yet progressive nature of biotech and pharma companies. From advancements in specific treatments to significant executive shifts, the landscape seems
In a move that promises to set new standards in supply chain sustainability, DHL Supply Chain has joined forces with biopharmaceutical company Boehringer Ingelheim to transform its warehousing and logistics operations in Australia and New Zealand. The partnership aims to enhance efficiency,
